Compare CXDO & PMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CXDO | PMI |
|---|---|---|
| Founded | 1995 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | |
| Sector | Telecommunications | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.1M | 202.7M |
| IPO Year | 1999 | N/A |
| Metric | CXDO | PMI |
|---|---|---|
| Price | $6.59 | $0.95 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $9.20 | N/A |
| AVG Volume (30 Days) | ★ 123.4K | 113.6K |
| Earning Date | 05-05-2026 | 03-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 166.67 | N/A |
| EPS | ★ 0.16 | N/A |
| Revenue | ★ $68,167,000.00 | N/A |
| Revenue This Year | $45.41 | N/A |
| Revenue Next Year | $13.20 | N/A |
| P/E Ratio | $40.44 | ★ N/A |
| Revenue Growth | ★ 12.05 | N/A |
| 52 Week Low | $4.14 | $0.90 |
| 52 Week High | $7.80 | $13.68 |
| Indicator | CXDO | PMI |
|---|---|---|
| Relative Strength Index (RSI) | 57.29 | 40.02 |
| Support Level | $6.54 | $0.92 |
| Resistance Level | $6.71 | $1.37 |
| Average True Range (ATR) | 0.25 | 0.07 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 93.53 | 23.23 |
Crexendo Inc is a provider of cloud communications, UCaaS, call centers, collaboration services, and other cloud business services. The company operates through two segments: Cloud telecommunications and Software Solutions. Its cloud telecommunications segment offers hardware, software, and unified communication solutions for businesses using IP or cloud technology over any high-speed Internet connection. The Software Solutions segment is involved in revenue generation from software licenses, software maintenance support, and professional services. It generates subscription and maintenance support revenue from customer support and other supportive services. The company offers warranties on its products. It derives a majority of its revenue from the Cloud telecommunications segment.
Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.